Long-acting Injectable Antipsychotics and Stigma: Some Considerations and Future Perspectives

Curr Pharm Des. 2023;29(13):981-983. doi: 10.2174/1381612829666230406102039.

Authors

Antimo Natale¹, Laura Fusar-Poli^{1

2}, Andrea Amerio^{3

4}, Andrea Escelsior^{3

4}, Gianluca Serafini^{3

4}, Eugenio Aguglia¹, Mario Amore^{3

4}, Andrea Aguglia^{3

4}

Affiliations

¹ Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
² Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
³ Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Section of Psychiatry, University of Genoa, Genoa, Italy.
⁴ Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Ospedale Policlinico San Martino, Genoa, Italy.

PMID: 37038686
DOI: 10.2174/1381612829666230406102039

No abstract available

Publication types

Editorial

MeSH terms

Antipsychotic Agents* / therapeutic use
Delayed-Action Preparations
Humans
Schizophrenia* / drug therapy

Substances

Antipsychotic Agents
Delayed-Action Preparations